Littlejohn & Co’s Insmed INSM Stock Holding History

Littlejohn & Co’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$1.36M	–	31
2024 Q1	$1.36M	Buy	+50,000	New	+$1.4M	0.87%	12

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Littlejohn & Co's INSM Position: Q2 2024 in Review

Littlejohn & Co sold out of Insmed (INSM) in Q2 2024, closing a stake of 50,000 shares — an estimated $1.36M sold.

Littlejohn & Co first reported a position in INSM in Q1 2024 and held it in 1 quarter. The position peaked at $1.36M in Q1 2024. 378 funds tracked by Wall St. Rank hold INSM as of Q2 2024.

Littlejohn & Co reported no remaining Insmed position as of Q2 2024 after selling out during the quarter.
Littlejohn & Co sold 50,000 Insmed shares in Q2 2024, an estimated $1.36M.
Littlejohn & Co first reported a position in Insmed in Q1 2024 and held it in 1 quarter.
Littlejohn & Co's Insmed position peaked at $1.36M in Q1 2024.
378 funds tracked by Wall St. Rank held Insmed as of Q2 2024.

Based on Littlejohn & Co's 13F filing for Q2 2024, filed 13 Aug 2024.